Literature DB >> 11849686

Validation of a luminescence immunoassay for the detection of PrP(Sc) in brain homogenate.

Karin Biffiger1, Daniel Zwald, Lukas Kaufmann, Alexandra Briner, Inci Nayki, Mario Pürro, Sigrid Bottcher, Thomas Struckmeyer, Olivier Schaller, Rudolf Meyer, Rosemarie Fatzer, Andres Zurbriggen, Mick Stack, Markus Moser, Bruno Oesch, Eric Kübler.   

Abstract

A luminescence immunoassay (LIA) was developed for the diagnosis of bovine spongiform encephalopathy (BSE) in brain tissue using two different monoclonal antibodies for capture and detection of the protease-resistant fragment of the pathological prion protein (PrP27-30). PrP27-30 currently represents the most reliable marker for the infectious particle (denominated prion) causing transmissible spongiform encephalopathies (TSEs). Internal and official validation studies of this assay are described using brain homogenates from ascertained BSE positive and negative cows. Using more than 300 positive and 1400 negative bovine or ovine samples, an excellent sensitivity and specificity of 100% were demonstrated. More than 1000-fold dilutions of a BSE positive homogenate still resulted in a clear positive signal. In combination with a simple homogenisation procedure for the preparation of the samples, this assay lends itself for large scale screening of cattle and sheep for TSEs using complete automation of the process.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11849686     DOI: 10.1016/s0166-0934(01)00421-9

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  6 in total

1.  Use of thermolysin in the diagnosis of prion diseases.

Authors:  Jonathan P Owen; Ben C Maddison; Garry C Whitelam; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

2.  Mass spectrometric detection of attomole amounts of the prion protein by nanoLC/MS/MS.

Authors:  Bruce Onisko; Irina Dynin; Jesús R Requena; Christopher J Silva; Melissa Erickson; John Mark Carter
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-28       Impact factor: 3.109

3.  Absolute quantification of prion protein (90-231) using stable isotope-labeled chymotryptic peptide standards in a LC-MRM AQUA workflow.

Authors:  Robert Sturm; Gloria Sheynkman; Clarissa Booth; Lloyd M Smith; Joel A Pedersen; Lingjun Li
Journal:  J Am Soc Mass Spectrom       Date:  2012-06-20       Impact factor: 3.109

4.  Evaluation of the cumulative evidence for freedom from BSE in birth cohorts.

Authors:  Dankmar Böhning; Matthias Greiner
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

5.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

Review 6.  TSE diagnostics: recent advances in immunoassaying prions.

Authors:  Anja Lukan; Tanja Vranac; Vladka Curin Šerbec
Journal:  Clin Dev Immunol       Date:  2013-07-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.